ci 994 has been researched along with Atrial Fibrillation in 1 studies
tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seki, M | 1 |
| LaCanna, R | 1 |
| Powers, JC | 1 |
| Vrakas, C | 1 |
| Liu, F | 1 |
| Berretta, R | 1 |
| Chacko, G | 1 |
| Holten, J | 1 |
| Jadiya, P | 1 |
| Wang, T | 1 |
| Arkles, JS | 1 |
| Copper, JM | 1 |
| Houser, SR | 1 |
| Huang, J | 1 |
| Patel, VV | 1 |
| Recchia, FA | 1 |
1 other study available for ci 994 and Atrial Fibrillation
| Article | Year |
|---|---|
Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.
Topics: Adipocytes; Animals; Atrial Fibrillation; Atrial Remodeling; B-Lymphocytes; Benzamides; Biomarkers; | 2016 |